p53 Mutations in Deep Tissues Are More Strongly Associated with Recurrence than Mutation-Positive Mucosal Margins

Purpose: Application of ultrasensitive diagnostics has shown that small numbers of p53 mutation-positive cells may signify the presence of residual tumor in histologically normal tissues after resection of squamous cell carcinomas arising in the head and neck area. To date, most studies in this area have focused on analysis of tissues at the mucosal aspect of the resection and highlighted the importance of molecular changes in the field with respect to the risk of recurrence. Experimental Design: In the present investigation, we analyzed normal tissues from mucosal and deep surgical margins, referred to as “molecular margins,” for the presence of the signature p53 mutation identified for each tumor. Results: The p53 mutation status of these carcinomas did not correlate with clinical or histopathologic variables, but these mutations provided an excellent target for ultrasensitive analysis of margin status. We found that 11 of 16 (68%) of cases with histologically tumor-free (including 9 without dysplasia), but with p53 mutation-positive molecular margins, developed recurrence. The probability of developing local recurrence was significantly higher for the group with p53 mutation-positive margins when compared with the group with clear margins (P = 0.048) and more strongly associated with p53 mutation-positive deep molecular margins than mutation-positive mucosal molecular margins or positivity at both sites (P = 0.009). Conclusions: This shows that although persistent mucosal fields may contribute to recurrence, clonal p53 mutations in deep tissues are an important cause of treatment failure, and molecular margins from both sites should be analyzed in future prospective series.

[1]  J. Woolgar,et al.  Histopathological prognosticators in oral and oropharyngeal squamous cell carcinoma. , 2006, Oral oncology.

[2]  J. Woolgar,et al.  A histopathological appraisal of surgical margins in oral and oropharyngeal cancer resection specimens. , 2005, Oral oncology.

[3]  M. Partridge,et al.  Molecular analysis of paired tumours: time to start treating the field. , 2005, Oral oncology.

[4]  C. R. Leemans,et al.  Expanding fields of genetically altered cells in head and neck squamous carcinogenesis. , 2005, Seminars in cancer biology.

[5]  R. Hruban,et al.  LigAmp for sensitive detection of single-nucleotide differences , 2004, Nature Methods.

[6]  J. Lee,et al.  Tetranucleotide Microsatellite Instability in Surgical Margins for Prediction of Local Recurrence of Head and Neck Squamous Cell Carcinoma , 2004, Clinical Cancer Research.

[7]  C. R. Leemans,et al.  Molecular Diagnosis of Surgical Margins and Local Recurrence in Head and Neck Cancer Patients , 2004, Clinical Cancer Research.

[8]  David C. Thomas,et al.  Real-Time Gap Ligase Chain Reaction , 2004, Clinical Cancer Research.

[9]  R. Hooper,et al.  Detection of rare disseminated tumor cells identifies head and neck cancer patients at risk of treatment failure. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[10]  G. Snow,et al.  Mutated p53 as a molecular marker for the diagnosis of head and neck cancer , 2002, The Journal of pathology.

[11]  G. Giaccone Clinical impact of novel treatment strategies , 2002, Oncogene.

[12]  C. R. Leemans,et al.  Multiple head and neck tumors frequently originate from a single preneoplastic lesion. , 2002, The American journal of pathology.

[13]  P. Slootweg,et al.  Treatment failure and margin status in head and neck cancer. A critical view on the potential value of molecular pathology. , 2002, Oral oncology.

[14]  C. R. Leemans,et al.  Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions. , 2002, Head & neck.

[15]  A. Franchi,et al.  Prediction of recurrence by microsatellite analysis in head and neck cancer , 2000, Genes, chromosomes & cancer.

[16]  R. A’Hern,et al.  A case-control study confirms that microsatellite assay can identify patients at risk of developing oral squamous cell carcinoma within a field of cancerization. , 2000, Cancer research.

[17]  J. Langdon,et al.  Detection of minimal residual cancer to investigate why oral tumors recur despite seemingly adequate treatment. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[18]  K Raja,et al.  Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease. , 2000, Cancer research.

[19]  R. Spiro,et al.  Pattern of invasion and margin assessment in patients with oral tongue cancer , 1999, Head & neck.

[20]  S. Rogers,et al.  Survival and patterns of recurrence in 200 oral cancer patients treated by radical surgery and neck dissection. , 1999, Oral oncology.

[21]  R. Iggo,et al.  High frequency of p53 mutations in human oral epithelial dysplasia and primary squamous cell carcinoma detected by yeast functional assay , 1997, Oncogene.

[22]  R A Robinson,et al.  Quantification of surgical margin shrinkage in the oral cavity , 1997, Head & neck.

[23]  R. Iggo,et al.  Field cancerisation and polyclonal p53 mutation in the upper aero- digestive tract , 1997, Oncogene.

[24]  E. Gabrielson,et al.  Multiple head and neck tumors: evidence for a common clonal origin. , 1996, Cancer research.

[25]  R H Hruban,et al.  Molecular assessment of histopathological staging in squamous-cell carcinoma of the head and neck. , 1995, The New England journal of medicine.

[26]  E. Strong,et al.  Significance of positive margins in oral cavity squamous carcinoma. , 1990, American journal of surgery.

[27]  Y. Barrandon,et al.  Three clonal types of keratinocyte with different capacities for multiplication. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[28]  N. Johnson,et al.  Prognostic significance of STNMp and velocity of tumor growth in oral cancer , 1982, Cancer.

[29]  G. Schwarz Estimating the Dimension of a Model , 1978 .

[30]  K. Gaballah,et al.  Molecular markers for diagnosis and prognosis , 2005, Cancer and Metastasis Reviews.

[31]  P D Bezemer,et al.  The clinical relevance of epithelial dysplasia in the surgical margins of tongue and floor of mouth squamous cell carcinoma: an analysis of 37 patients. , 2002, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[32]  A. Raftery Bayesian Model Selection in Social Research , 1995 .